Factors Affecting Cellulolysis by Ruminococcus Albus W

Total Page:16

File Type:pdf, Size:1020Kb

Factors Affecting Cellulolysis by Ruminococcus Albus W JouRNAL oF BAcrTOLOGY, May 1973, p. 729-737 Vol. 114, No. 2 Copyright 0 1973 American Society for Microbiology Printed in U.S.A. Factors Affecting Cellulolysis by Ruminococcus albus W. R. SMITH,' IDA YU, AND R. E. HUNGATE Department of Bacteriology, University of California, Davis, California 95616 Received for publication 10 November 1972 The factors influencing the digestion of pebble-milled cellulose by enzymes were studied by using several strains of Ruminococcus albus including a mutant characterized by a more eccentric location of its colony in the clearing produced by digestion of the cellulose in the thin layer lining the wall of a culture tube. Most of the cellulase is extracellular. As much as 65% of the cellulose could be digested by the cell-free enzymes provided the quantity of cellulose was small. Fresh enzyme was repeatedly administered or the digestion experiment was arranged in a dialysis bag through which digestion products could diffuse. Cellobiose and, to a lesser extent, glucose inhibited digestion. Pebble-milled filter paper, moist crystalline cellulose from cotton, and dry crystalline cellulose (Sigmacel) were digested, but in decreasing rapidity, respectively. Carboxymeth- ylcellulose was digested more rapidly than pebble-milled cellulose but to approximately the same final extent as judged by Cu reduction values. Cell walls from alfalfa were digested. The enzyme preparation was active over the pH range 6.0 to 6.8 and showed most rapid cellulose digestion at 45 C. Part of the cellulolytic activity was irreversibly destroyed by exposure to oxygen. Much of the enzyme was absorbed on cellulose. The absorption and desorption character- istics, as well as the partial inhibition by oxygen, indicate that multiple enzymes are involved. Much cellulose is digested in the rumen. single colony growing in cellulose agar inocu- Cell-free cellulose-digesting extracts of mixed lated with strain 6 (Fig. la). Leatherwood (11) rumen bacteria have been obtained (9), and a has ascribed cleared zones to the combined multiplicity of cellulases has been demon- action of two cellulases and a non-cellulolytic strated (7, 8). molecule. The zones from his strains were Of the numerous cellulolytic bacteria isolated circular, with the colony much nearer the center from the rumen, strains resembling the type than was the case with our strains, although his strain of Ruminococcus albus (4) are among the photographs (11) suggest a slightly eccentric most active. The agar is entirely cleared of location. cellulose around colonies in agar roll tubes, with When the agar medium in which R. albus is a sharp border between digested and undigested growing also contains cellobiose, the cellulose substrate (Fig. la). The separation of the colony around the colony does not clear until most of from the site of digestion shows that the enzyme the cellobiose has been fermented (6), an ob- is extracellular. The colony is located eccentri- servation suggesting involvement of cellobiose cally (its distance from the upper border of in some sort of control mechanism. This phe- cellulose digestion being less than from the nomenon has been observed also by Fusee and lower border) in the oval clearing when the Leatherwood (2) who reported evidence for a colony grows in a thin agar layer lining the cellobiose repression of cellulase production. inner wall of a vertically incubated culture Of the cellulase activity in rumen contents, tube, but is located in the center of a circular 20% was ascribed to R. albus on the basis of the clearing in a horizontally incubated layer. Even decrease in cellulolysis caused by antiserum greater eccentricity of the colony location oc- specific against the cellulase of a strain of R. curred in strain 6L (Fig. lb), noted first as a albus (10). This paper reports on the cellulolytic activity 'Present address: G. D. Searle & Co. Ltd., High Wy- of the mixed enzymes of R. albus and on the combe, Bucks., England. factors affecting it. 729 730 SMITH, YU, AND HUNGATE J. BACTERIOL. strain was grown in continuous culture (8-h cycle time) on 0.1% cellobiose by previously described methods (5). Yeast extract (0.1%, Difco) added to batch cultures on minimal medium supported more rapid growth initially, but continuous cultures with added yeast extract failed to grow after 7 days. In contrast, a continuous culture containing 10% rumen fluid ran successfully for 3 months on cellobiose without losing the capacity for cellulase production when inoculated into cellulose agar medium. In most experiments, enzyme was from batch cultures grown on rumen fluid plus cellobiose or cellulose. The RAM strain was used unless otherwise indicated. Substrates. Pebble-milled cellulose (PMC) was prepared by tearing up 30 g of Whatman no. 1 filter paper and placing it in a porcelain jar (ca. 4-liter capacity) with one liter of water. Enough flint pebbles were used so that the liquid just covered them. The jar was rolled for 24 h at 74 rpm. The liquid containing the cellulose was drained off, and the pebbles were washed with enough water to bring the milled cel- lulose to a concentration of 20 mg/ml. Carboxymethyl- cellulose (CMC) was obtained as product 70M from Hercules Powder Co. Powdered crystalline cel- lulose (Sigmacel) was obtained from Sigma Chemical Co. It was suspended in distilled water and auto- claved at 15 lb/in2 for 20 min. Crystalline cellulose, FIG. 1. Colonies of strain 6 (a) and strain 6L (b) in which was never dried after preparation, was obtained the thin layer of cellulose agar lining the wall of a roll by heating 5 g of absorbent cotton in 220 ml of 2.5 N tube. HCI for 20 min (preparation A) or 45 min (preparation B) at 103 C. The insoluble residue was collected, washed on a Buchner funnel, and suspended in 150 MATERIALS AND METHODS ml of water with the aid of a Waring blend6r. Bacterial strains. Cultures of R. albus strain RAM Alfalfa cell walls were prepared by picking the tops in a were grown in a balanced mineral solution containing of lush prebloom alfalfa and mincing them biotin, aminobenzoic acid, pyridoxin, isobutyrate, Waring blendor which contained water. The blended isovalerate, and 2-methylbutyrate (5). This medium material was transferred to a graduated cylinder, and is designated minimal medium. With addition of the particles were allowed to settle. The suspension in and cellulose or cellobiose and some rumen fluid (2 to 33%, the lower part of the cylinder was again blended water vol/vol) it was designated the stock culture medium. retumed to the cylinder for mixing with wash The mineral portion, including 0.5% sodium bicar- and for settling. The coarsest particles were filtered bonate, 0.03% Na2S-9H2O, and 0.03% cysteine hydro- off with a seive, and the suspension of small particles chloride, equilibrated with O2-free CO2, is designated was washed repeatedly by sedimentation until little mineral medium. chlorophyll could be seen. Sodium hydroxide (1%, At times it was difficult to maintain the strain in wt/vol) was added, the washing process was re- vigorous cellulolytic condition during repeated trans- peated until the pH of the wash water was almost neu- fers in the cellulose rumen fluid agar medium. Occa- tral, and then the pH was adjusted to 7.0 with HCl. sionally, vigor could be at least partially regained by Alfalfa cell walls prepared in this way did not give the subculturing in 30% rumen fluid cellulose liquid blue color characteristic of cellulose treated with 70% medium and then inoculating a 10% rumen fluid H2SO4 plus iodine. cellulose agar dilution series from which an actively For enzyme experiments, the aqueous suspension of cellulolytic colony was picked. Revived cultures grew the cellulosic substrate (except CMC) was centrifuged well in the minimal medium alone (or with 2% rumen to give a pellet, and the supernatant fluid was poured fluid) but were not always identical to the strain off to avoid dilution of the enzyme preparation. The before its revival. By selecting the most actively centrifuge tube was gassed out to exclude 02, the cellulolytic colonies, cellulolysis was preserved, but enzyme solution and toluene were added, and the the activity after 3 years in culture fell to about half tube and contents were treated as desired. that of the original and was less than that of the two Measurement of cellulase activity. Cultures were more recently isolated strains, 6 and N3. These strains usually grown on 0.1 or 0.2% cellobiose or cellulose. in turn showed changes leading to a gradual reduction Exposure of cells and enzyme to atmospheric oxygen in cellulolytic activity. They were routinely cultured was avoided at all steps by using closed containers on clarified rumen fluid (33%, vol/vol) added to gassed out with CO2 freed of oxygen by passage over mineral agar medium containing cellulose. hot Cu. The cells in a spent culture were sedimented During initial enzyme experiments, the RAM by centrifugation at 10,000 x g for 20 min, and the VOL. 114, 1973 CELLULOLYSIS BY R. ALBUS 731 supernatant fluid was used as the source of enzyme. In the entire 800 ml of culture. Since the superna- some experiments the supernatant fluid was first tant fluid showed good activity and its enzymes filtered through a membrane filter (0.45-Am porosity; presumably resembled those in the cells, it was Millipore Corp.). Toluene was added to the superna- tant fluid if cells had not been removed by filtration. used as the source of enzyme in all subsequent It did not diminish cellulase activity. experiments. Use of the supernatant fluid The solution to be tested for cellulase was in- avoided the problem of separating the intracel- cubated with the substrate at 39 C for various periods.
Recommended publications
  • The Crystal Structure of the N-Acetylglucosamine 2-Epimerase from Nostoc Sp
    research papers The crystal structure of the N-acetylglucosamine 2-epimerase from Nostoc sp. KVJ10 reveals the true dimer ISSN 2059-7983 Marie-Jose´e Haglund Halsør, Ulli Rothweiler, Bjørn Altermark and Inger Lin Uttakleiv Raeder* Received 26 September 2018 The Norwegian Structural Biology Centre (NorStruct), Department of Chemistry, UiT – The Arctic University of Norway, Accepted 30 November 2018 9037 Tromsø, Norway. *Correspondence e-mail: [email protected] Edited by M. Czjzek, Station Biologique de N-Acetylglucosamine 2-epimerases (AGEs) catalyze the interconversion of Roscoff, France N-acetylglucosamine and N-acetylmannosamine. They can be used to perform the first step in the synthesis of sialic acid from N-acetylglucosamine, which Keywords: N-acetylglucosamine 2-epimerase; makes the need for efficient AGEs a priority. This study presents the structure of AGE; sialic acid; crystal packing; ManNAc; the AGE from Nostoc sp. KVJ10 collected in northern Norway, referred to as GlcNAc; N-acetylmannosamine; Nostoc sp. nAGE10. It is the third AGE structure to be published to date, and the first one KVJ10. in space group P42212. The nAGE10 monomer folds as an ( / )6 barrel in a PDB reference: N-acetylglucosamine similar manner to that of the previously published AGEs, but the crystal did not 2-epimerase, 6f04 contain the dimers that have previously been reported. The previously proposed ‘back-to-back’ assembly involved the face of the AGE monomer where the Supporting information: this article has barrel helices are connected by small loops. Instead, a ‘front-to-front’ dimer was supporting information at journals.iucr.org/d found in nAGE10 involving the long loops that connect the barrel helices at this end.
    [Show full text]
  • Cellobiose 2-Epimerase, Process for Producing
    (19) TZZ ¥ZZ_T (11) EP 2 395 080 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12N 15/00 (2006.01) C12N 1/15 (2006.01) 06.08.2014 Bulletin 2014/32 C12N 1/19 (2006.01) C12N 1/21 (2006.01) C12N 5/10 (2006.01) C12N 9/90 (2006.01) (2006.01) (2006.01) (21) Application number: 10738433.1 C12N 15/09 C12P 19/00 (22) Date of filing: 25.01.2010 (86) International application number: PCT/JP2010/050928 (87) International publication number: WO 2010/090095 (12.08.2010 Gazette 2010/32) (54) CELLOBIOSE 2-EPIMERASE, PROCESS FOR PRODUCING SAME, AND USE OF SAME CELLOBIOSE 2-EPIMERASE, HERSTELLUNGSVERFAHREN DAFÜR UND VERWENDUNG CELLOBIOSE 2-ÉPIMÉRASE, PROCÉDÉ DE PRODUCTION DE CELLE-CI ET UTILISATION DE CELLE-CI (84) Designated Contracting States: (74) Representative: Daniels, Jeffrey Nicholas AT BE BG CH CY CZ DE DK EE ES FI FR GB GR Page White & Farrer HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL Bedford House PT RO SE SI SK SM TR John Street London WC1N 2BF (GB) (30) Priority: 05.02.2009 JP 2009025070 (56) References cited: (43) Date of publication of application: WO-A1-2008/062555 14.12.2011 Bulletin 2011/50 • PARK CHANG-SU ET AL: "Characterization of a (73) Proprietor: Hayashibara Co., Ltd. recombinant cellobiose 2-epimerase from Okayama-shi, Okayama (JP) Caldicellulosiruptor saccharolyticus and its application in the production of mannose from (72) Inventors: glucose.", APPLIED MICROBIOLOGY AND • WATANABE Hikaru BIOTECHNOLOGY DEC 2011 LNKD- PUBMED: Okayama-shi 21691788,vol.
    [Show full text]
  • Along the Path of Bacterial Nonulosonic Acids
    Faculty of Science and Technology Along the path of bacterial nonulosonic acids A study of the bio- and in vitro synthesis of sialic acid related compounds — Marie-Josée Haglund Halsør A dissertation for the degree of Philosophiae Doctor – June 2019 Along the path of nonulosonic acids A study of the bio- and in vitro synthesis of sialic acid related compounds Marie-Josée Haglund Halsør A dissertation for the degree of Philosophiae Doctor FACULTY OF SCIENCE AND TECHNOLOGY DEPARTMENT OF CHEMISTRY June 2019 "There is a single light of science and to brighten it anywhere is to brighten it everywhere." - Unsourced, credited to Isaac Asimov. Preface “Why?”, and later “How?”. Those two questions are what led me to research, without doubt. I’ve asked them (aloud or not) every day for as long as I can remember, about practically everything. The other thing is being amazed by Nature. The diversity of every aspect and how it all functions as one, somehow. My favorite as a child were the documentaries by “le Commandant Cousteau” (the sharks!), and my dream was to be an oceanographer. I pursued that dream up until my first year of university, when I discovered biochemistry. I had already grown a liking for chemistry, and it was the only discipline that answered the “biological whys and hows” without going into physics. Biochemistry studies and does, both trying to unravel Nature’s secrets and building its own means to do so. It also uses the knowledge to improve human living conditions, at least in theory. I was sold, and here I am.
    [Show full text]
  • 12) United States Patent (10
    US007635572B2 (12) UnitedO States Patent (10) Patent No.: US 7,635,572 B2 Zhou et al. (45) Date of Patent: Dec. 22, 2009 (54) METHODS FOR CONDUCTING ASSAYS FOR 5,506,121 A 4/1996 Skerra et al. ENZYME ACTIVITY ON PROTEIN 5,510,270 A 4/1996 Fodor et al. MICROARRAYS 5,512,492 A 4/1996 Herron et al. 5,516,635 A 5/1996 Ekins et al. (75) Inventors: Fang X. Zhou, New Haven, CT (US); 5,532,128 A 7/1996 Eggers Barry Schweitzer, Cheshire, CT (US) 5,538,897 A 7/1996 Yates, III et al. s s 5,541,070 A 7/1996 Kauvar (73) Assignee: Life Technologies Corporation, .. S.E. al Carlsbad, CA (US) 5,585,069 A 12/1996 Zanzucchi et al. 5,585,639 A 12/1996 Dorsel et al. (*) Notice: Subject to any disclaimer, the term of this 5,593,838 A 1/1997 Zanzucchi et al. patent is extended or adjusted under 35 5,605,662 A 2f1997 Heller et al. U.S.C. 154(b) by 0 days. 5,620,850 A 4/1997 Bamdad et al. 5,624,711 A 4/1997 Sundberg et al. (21) Appl. No.: 10/865,431 5,627,369 A 5/1997 Vestal et al. 5,629,213 A 5/1997 Kornguth et al. (22) Filed: Jun. 9, 2004 (Continued) (65) Prior Publication Data FOREIGN PATENT DOCUMENTS US 2005/O118665 A1 Jun. 2, 2005 EP 596421 10, 1993 EP 0619321 12/1994 (51) Int. Cl. EP O664452 7, 1995 CI2O 1/50 (2006.01) EP O818467 1, 1998 (52) U.S.
    [Show full text]
  • POLSKIE TOWARZYSTWO BIOCHEMICZNE Postępy Biochemii
    POLSKIE TOWARZYSTWO BIOCHEMICZNE Postępy Biochemii http://rcin.org.pl WSKAZÓWKI DLA AUTORÓW Kwartalnik „Postępy Biochemii” publikuje artykuły monograficzne omawiające wąskie tematy, oraz artykuły przeglądowe referujące szersze zagadnienia z biochemii i nauk pokrewnych. Artykuły pierwszego typu winny w sposób syntetyczny omawiać wybrany temat na podstawie możliwie pełnego piśmiennictwa z kilku ostatnich lat, a artykuły drugiego typu na podstawie piśmiennictwa z ostatnich dwu lat. Objętość takich artykułów nie powinna przekraczać 25 stron maszynopisu (nie licząc ilustracji i piśmiennictwa). Kwartalnik publikuje także artykuły typu minireviews, do 10 stron maszynopisu, z dziedziny zainteresowań autora, opracowane na podstawie najnow­ szego piśmiennictwa, wystarczającego dla zilustrowania problemu. Ponadto kwartalnik publikuje krótkie noty, do 5 stron maszynopisu, informujące o nowych, interesujących osiągnięciach biochemii i nauk pokrewnych, oraz noty przybliżające historię badań w zakresie różnych dziedzin biochemii. Przekazanie artykułu do Redakcji jest równoznaczne z oświadczeniem, że nadesłana praca nie była i nie będzie publikowana w innym czasopiśmie, jeżeli zostanie ogłoszona w „Postępach Biochemii”. Autorzy artykułu odpowiadają za prawidłowość i ścisłość podanych informacji. Autorów obowiązuje korekta autorska. Koszty zmian tekstu w korekcie (poza poprawieniem błędów drukarskich) ponoszą autorzy. Artykuły honoruje się według obowiązujących stawek. Autorzy otrzymują bezpłatnie 25 odbitek swego artykułu; zamówienia na dodatkowe odbitki (płatne) należy zgłosić pisemnie odsyłając pracę po korekcie autorskiej. Redakcja prosi autorów o przestrzeganie następujących wskazówek: Forma maszynopisu: maszynopis pracy i wszelkie załączniki należy nadsyłać w dwu egzem­ plarzach. Maszynopis powinien być napisany jednostronnie, z podwójną interlinią, z marginesem ok. 4 cm po lewej i ok. 1 cm po prawej stronie; nie może zawierać więcej niż 60 znaków w jednym wierszu nie więcej niż 30 wierszy na stronie zgodnie z Normą Polską.
    [Show full text]
  • Supplementary Information
    Supplementary Information Genomic analyses of Bifidobacterium moukalabense reveal adaptations to fruigivore/folivore feeding behavior Takahiro Segawa, Satoshi Fukuchi, Dylan Bodington, Sayaka Tsutida, Pierre Philippe Mbehang Nguema, Hishiro Mori, Kazunari Ushida This PDF file includes: Supplementary Figures 1-5 Supplementary Tables 1-10 GB03 GB04 95 GB01 Bifidobacterium moukalabense JCM 18751T (GG01T) 98 GB62 CD14 100 95 CD16 EB44 CD33 40 GB63 99 GB65 67 EB43 36 T Bifidobacterium catenulatum JCM 1194 99 T Bifidobacterium pseudocatenulatum JCM 1200 T Bifidobacterium merycicum JCM 8219 T Bifidobacterium dentium JCM 1195 T Bifidobacterium ruminantium JCM 8222 46 T Bifidobacterium faecale JCM 19861 100 T 37 Bifidobacterium adolescentis JCM 1275 56 41 T Bifidobacterium stercoris JCM 15918 T Bifidobacterium callitrichos JCM 17296 T Bifidobacterium kashiwanohense JCM 15439 T 45 Bifidobacterium biavatii JCM 17299 T Bifidobacterium bifidum JCM 1255 T 95 Bifidobacterium aesculapii JCM18761 T Bifidobacterium stellenboschense JCM 17298 T Bifidobacterium angulatum JCM 7096 72 T Bifidobacterium scardovii JCM 12489 T 100 Bifidobacterium gallinarum JCM 6291 100 T Bifidobacterium saeculare JCM 8223 T Bifidobacterium pullorum JCM 1214 T 60 Bifidobacterium animalis subsp. animalis JCM 1190 91 T Bifidobacterium choerinum JCM 1212 T 98 Bifidobacterium pseudolongum subsp. pseudolongum JCM 1205 T Bifidobacterium gallicum JCM 8224 T 63 Bifidobacterium cunniculi JCM 1213 77 T Bifidobacterium magnum JCM 1218 T 99 Bifidobacterium asteroids JCM 8230 69 T Bifidobacterium coryneforme JCM 5819 47 T Bifidobacterium actinocoloniiforme JCM 18048 T Bifidobacterium tsurumiense JCM 13495 T Bifidobacterium reuteri JCM 17295 T Bifidobacterium thermophilum JCM 1207 63 T 92 Bifidobacterium boum JCM 1211 96 T Bifidobacterium thermacidophilum subsp. thermacidophilum JCM 11165 T Bifidobacterium subtile DSM 20096 T Bifidobacterium lemurum JCM 30168 45 T Bifidobacterium breve JCM 1192 55 T Bifidobacterium saguini JCM 17297 68 Bifidobacterium indicum JCM 1302T 46 100 Bifidobacterium longum subsp.
    [Show full text]
  • Studies on Enzymatic Synthesis of Functional Sugars
    Studies on enzymatic synthesis of functional sugars A Dissertation Submitted to the Graduate School of Bioagricultural Sciences, Nagoya University in Partial Fulfillment of the Requirements for the Degree of Doctor of Agricultural Sciences March, 2013 Teruyo Ojima Laboratory of Molecular Biotechnology, Division of Biotechnology, Department of Bioengineering Sciences, Graduate School of Bioagricultural Sciences, Nagoya University Table of contents (page) Abbreviations ................................................................................................... 1 Chapter 1. General introduction ...................................................................... 3 1.1. Enzymatic synthesis of sugars ................................................................. 3 1.2. Value added sugars ................................................................................. 3 1.3. α-Glucosidase and glucoside ................................................................... 3 1.3.1 α-Glucosidase .................................................................................... 3 1.3.2. Industrial application of α-glucosidase .............................................. 5 1.3.3. Enzymatic synthesis of glucosides .................................................... 6 1.3.4. Problems in the synthesis of glucoside ............................................. 6 1.4. Cellobiose 2-epimerase and epilactose ................................................... 8 1.4.1. Research history of cellobiose 2-epimerase .....................................
    [Show full text]
  • The Chemistry and Evolution of Enzyme Function
    The Chemistry and Evolution of Enzyme Function: Isomerases as a Case Study Sergio Mart´ınez Cuesta EMBL - European Bioinformatics Institute Gonville and Caius College University of Cambridge A thesis submitted for the degree of Doctor of Philosophy 31st July 2014 This dissertation is the result of my own work and contains nothing which is the outcome of work done in collaboration except where specifically indicated in the text. No part of this dissertation has been submitted or is currently being submitted for any other degree or diploma or other qualification. This thesis does not exceed the specified length limit of 60.000 words as defined by the Biology Degree Committee. This thesis has been typeset in 12pt font using LATEX according to the specifications de- fined by the Board of Graduate Studies and the Biology Degree Committee. Cambridge, 31st July 2014 Sergio Mart´ınezCuesta To my parents and my sister Contents Abstract ix Acknowledgements xi List of Figures xiii List of Tables xv List of Publications xvi 1 Introduction 1 1.1 Chemistry of enzymes . .2 1.1.1 Catalytic sites, mechanisms and cofactors . .3 1.1.2 Enzyme classification . .5 1.2 Evolution of enzyme function . .6 1.3 Similarity between enzymes . .8 1.3.1 Comparing sequences and structures . .8 1.3.2 Comparing genomic context . .9 1.3.3 Comparing biochemical reactions and mechanisms . 10 1.4 Isomerases . 12 1.4.1 Metabolism . 13 1.4.2 Genome . 14 1.4.3 EC classification . 15 1.4.4 Applications . 18 1.5 Structure of the thesis . 20 2 Data Resources and Methods 21 2.1 Introduction .
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0266329 A1 Mathur Et Al
    US 2012026.6329A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0266329 A1 Mathur et al. (43) Pub. Date: Oct. 18, 2012 (54) NUCLEICACIDS AND PROTEINS AND CI2N 9/10 (2006.01) METHODS FOR MAKING AND USING THEMI CI2N 9/24 (2006.01) CI2N 9/02 (2006.01) (75) Inventors: Eric J. Mathur, Carlsbad, CA CI2N 9/06 (2006.01) (US); Cathy Chang, San Marcos, CI2P 2L/02 (2006.01) CA (US) CI2O I/04 (2006.01) CI2N 9/96 (2006.01) (73) Assignee: BP Corporation North America CI2N 5/82 (2006.01) Inc., Houston, TX (US) CI2N 15/53 (2006.01) CI2N IS/54 (2006.01) CI2N 15/57 2006.O1 (22) Filed: Feb. 20, 2012 CI2N IS/60 308: Related U.S. Application Data EN f :08: (62) Division of application No. 1 1/817,403, filed on May AOIH 5/00 (2006.01) 7, 2008, now Pat. No. 8,119,385, filed as application AOIH 5/10 (2006.01) No. PCT/US2006/007642 on Mar. 3, 2006. C07K I4/00 (2006.01) CI2N IS/II (2006.01) (60) Provisional application No. 60/658,984, filed on Mar. AOIH I/06 (2006.01) 4, 2005. CI2N 15/63 (2006.01) Publication Classification (52) U.S. Cl. ................... 800/293; 435/320.1; 435/252.3: 435/325; 435/254.11: 435/254.2:435/348; (51) Int. Cl. 435/419; 435/195; 435/196; 435/198: 435/233; CI2N 15/52 (2006.01) 435/201:435/232; 435/208; 435/227; 435/193; CI2N 15/85 (2006.01) 435/200; 435/189: 435/191: 435/69.1; 435/34; CI2N 5/86 (2006.01) 435/188:536/23.2; 435/468; 800/298; 800/320; CI2N 15/867 (2006.01) 800/317.2: 800/317.4: 800/320.3: 800/306; CI2N 5/864 (2006.01) 800/312 800/320.2: 800/317.3; 800/322; CI2N 5/8 (2006.01) 800/320.1; 530/350, 536/23.1: 800/278; 800/294 CI2N I/2 (2006.01) CI2N 5/10 (2006.01) (57) ABSTRACT CI2N L/15 (2006.01) CI2N I/19 (2006.01) The invention provides polypeptides, including enzymes, CI2N 9/14 (2006.01) structural proteins and binding proteins, polynucleotides CI2N 9/16 (2006.01) encoding these polypeptides, and methods of making and CI2N 9/20 (2006.01) using these polynucleotides and polypeptides.
    [Show full text]
  • All Enzymes in BRENDA™ the Comprehensive Enzyme Information System
    All enzymes in BRENDA™ The Comprehensive Enzyme Information System http://www.brenda-enzymes.org/index.php4?page=information/all_enzymes.php4 1.1.1.1 alcohol dehydrogenase 1.1.1.B1 D-arabitol-phosphate dehydrogenase 1.1.1.2 alcohol dehydrogenase (NADP+) 1.1.1.B3 (S)-specific secondary alcohol dehydrogenase 1.1.1.3 homoserine dehydrogenase 1.1.1.B4 (R)-specific secondary alcohol dehydrogenase 1.1.1.4 (R,R)-butanediol dehydrogenase 1.1.1.5 acetoin dehydrogenase 1.1.1.B5 NADP-retinol dehydrogenase 1.1.1.6 glycerol dehydrogenase 1.1.1.7 propanediol-phosphate dehydrogenase 1.1.1.8 glycerol-3-phosphate dehydrogenase (NAD+) 1.1.1.9 D-xylulose reductase 1.1.1.10 L-xylulose reductase 1.1.1.11 D-arabinitol 4-dehydrogenase 1.1.1.12 L-arabinitol 4-dehydrogenase 1.1.1.13 L-arabinitol 2-dehydrogenase 1.1.1.14 L-iditol 2-dehydrogenase 1.1.1.15 D-iditol 2-dehydrogenase 1.1.1.16 galactitol 2-dehydrogenase 1.1.1.17 mannitol-1-phosphate 5-dehydrogenase 1.1.1.18 inositol 2-dehydrogenase 1.1.1.19 glucuronate reductase 1.1.1.20 glucuronolactone reductase 1.1.1.21 aldehyde reductase 1.1.1.22 UDP-glucose 6-dehydrogenase 1.1.1.23 histidinol dehydrogenase 1.1.1.24 quinate dehydrogenase 1.1.1.25 shikimate dehydrogenase 1.1.1.26 glyoxylate reductase 1.1.1.27 L-lactate dehydrogenase 1.1.1.28 D-lactate dehydrogenase 1.1.1.29 glycerate dehydrogenase 1.1.1.30 3-hydroxybutyrate dehydrogenase 1.1.1.31 3-hydroxyisobutyrate dehydrogenase 1.1.1.32 mevaldate reductase 1.1.1.33 mevaldate reductase (NADPH) 1.1.1.34 hydroxymethylglutaryl-CoA reductase (NADPH) 1.1.1.35 3-hydroxyacyl-CoA
    [Show full text]
  • WO 2016/086208 Al 2 June 2016 (02.06.2016) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2016/086208 Al 2 June 2016 (02.06.2016) P O P C T (51) International Patent Classification: (74) Agents: MELLO, Jill Ann et al; McCarter & English, A61K 35/74 (2015.01) A61P 29/00 (2006.01) LLP, 265 Franklin Street, Boston, MA 021 10 (US). A61K 35/741 (2015.01) A61P 37/00 (2006.01) (81) Designated States (unless otherwise indicated, for every A61P 1/00 (2006.01) A61P 43/00 (2006.01) kind of national protection available): AE, AG, AL, AM, (21) International Application Number: AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, PCT/US20 15/062808 BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 25 November 2015 (25.1 1.2015) KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, (25) Filing Language: English MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (26) Publication Language: English SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, (30) Priority Data: TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. 62/084,537 25 November 2014 (25. 11.2014) US (84) Designated States (unless otherwise indicated, for every 62/084,536 25 November 2014 (25.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2015/0240226A1 Mathur Et Al
    US 20150240226A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2015/0240226A1 Mathur et al. (43) Pub. Date: Aug. 27, 2015 (54) NUCLEICACIDS AND PROTEINS AND CI2N 9/16 (2006.01) METHODS FOR MAKING AND USING THEMI CI2N 9/02 (2006.01) CI2N 9/78 (2006.01) (71) Applicant: BP Corporation North America Inc., CI2N 9/12 (2006.01) Naperville, IL (US) CI2N 9/24 (2006.01) CI2O 1/02 (2006.01) (72) Inventors: Eric J. Mathur, San Diego, CA (US); CI2N 9/42 (2006.01) Cathy Chang, San Marcos, CA (US) (52) U.S. Cl. CPC. CI2N 9/88 (2013.01); C12O 1/02 (2013.01); (21) Appl. No.: 14/630,006 CI2O I/04 (2013.01): CI2N 9/80 (2013.01); CI2N 9/241.1 (2013.01); C12N 9/0065 (22) Filed: Feb. 24, 2015 (2013.01); C12N 9/2437 (2013.01); C12N 9/14 Related U.S. Application Data (2013.01); C12N 9/16 (2013.01); C12N 9/0061 (2013.01); C12N 9/78 (2013.01); C12N 9/0071 (62) Division of application No. 13/400,365, filed on Feb. (2013.01); C12N 9/1241 (2013.01): CI2N 20, 2012, now Pat. No. 8,962,800, which is a division 9/2482 (2013.01); C07K 2/00 (2013.01); C12Y of application No. 1 1/817,403, filed on May 7, 2008, 305/01004 (2013.01); C12Y 1 1 1/01016 now Pat. No. 8,119,385, filed as application No. PCT/ (2013.01); C12Y302/01004 (2013.01); C12Y US2006/007642 on Mar. 3, 2006.
    [Show full text]